"The U.S. Food and Drug Administration today approved Hysingla ER (hydrocodone bitartrate), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternat"...
Synalgos-DC is contraindicated in patients with hypersensitivity to dihydrocodeine, codeine, or aspirin.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 6/4/2013
Additional Synalgos DC Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Chronic Pain/Back Pain
Find tips and advances in treatment.